Health Care Sector

Medium risk

VHT

growth
balanced
growth income

Top Holdings

331 Securities

Top Sector

Health Care

Min. Investment

$13,000

Expense Ratio

0.00%

Dividend Yield

1.47%

Description

This Strategy focuses on healthcare companies, including pharmaceuticals, biotechnology, healthcare providers, and medical equipment firms. Offering exposure to a sector driven by demographic trends and ongoing medical advancements, it's a strategic choice for investors considering healthcare's long-term growth potential.

Period From - To

Simulated Investment

Slippage (bps)

Rebalance Frequency

Generated using historical backtest simulation

Our interactive backtest tools is not reflective of actual live performance and these returns are hypothetical. Actual costs resulting from live trading may differ significantly, and backtest pricing data is not indicative realtime pricing data. Past performance is not an indicator of future performance. Learn more about how backtests work on Double here

Starting Point Holdings

NameSymbolAllocation
Eli Lilly & Co.LLY

10.31%

UnitedHealth Group, Inc.UNH

9.38%

Johnson & JohnsonJNJ

4.71%

AbbVie, Inc.ABBV

4.55%

Merck & Co., Inc.MRK

4%

Abbott LaboratoriesABT

3.43%

Thermo Fisher Scientific, Inc.TMO

3.32%

Intuitive Surgical, Inc.ISRG

3.24%

Danaher Corp.DHR

2.62%

Amgen, Inc.AMGN

2.56%

Pfizer Inc.PFE

2.41%

Stryker Corp.SYK

2.26%

Boston Scientific Corp.BSX

2.25%

Bristol Myers Squibb Co.BMY

2.02%

Vertex Pharmaceuticals, Inc.VRTX

1.97%

Gilead Sciences, Inc.GILD

1.88%

Medtronic PlcMDT

1.84%

Elevance Health, Inc.ELV

1.57%

The Cigna GroupCI

1.56%

Regeneron Pharmaceuticals, Inc.REGN

1.38%

Zoetis, Inc.ZTS

1.37%

McKesson Corp.MCK

1.36%

CVS Health Corp.CVS

1.22%

HCA Healthcare, Inc.HCA

1.11%

Becton, Dickinson & Co.BDX

1.09%

Cencora, Inc.COR

0.74%

Edwards Lifesciences Corp.EW

0.71%

Agilent Technologies, Inc.A

0.63%

GE Healthcare Technologies, Inc.GEHC

0.62%

Humana, Inc.HUM

0.6%

ResMed, Inc.RMD

0.59%

IQVIA Holdings, Inc.IQV

0.59%

IDEXX Laboratories, Inc.IDXX

0.58%

Veeva Systems, Inc.VEEV

0.55%

Centene Corp.CNC

0.54%

Alnylam Pharmaceuticals, Inc.ALNY

0.51%

DexCom, Inc.DXCM

0.5%

Cardinal Health, Inc.CAH

0.49%

Mettler-Toledo International, Inc.MTD

0.43%

Zimmer Biomet Holdings, Inc.ZBH

0.39%

Biogen, Inc.BIIB

0.38%

West Pharmaceutical Services, Inc.WST

0.37%

Illumina, Inc.ILMN

0.36%

STERIS Plc (Ireland)STE

0.36%

Waters Corp.WAT

0.35%

Labcorp Holdings, Inc.LH

0.34%

The Cooper Cos., Inc.COO

0.33%

Natera, Inc.NTRA

0.32%

Insulet Corp.PODD

0.31%

Hologic, Inc.HOLX

0.31%

Quest Diagnostics, Inc.DGX

0.31%

Molina Healthcare, Inc.MOH

0.29%

Baxter International, Inc.BAX

0.28%

Align Technology, Inc.ALGN

0.27%

Viatris, Inc.VTRS

0.27%

United Therapeutics Corp.UTHR

0.26%

Tenet Healthcare Corp.THC

0.25%

Revvity, Inc.RVTY

0.23%

Avantor, Inc.AVTR

0.21%

Moderna, Inc.MRNA

0.21%

Neurocrine Biosciences, Inc.NBIX

0.21%

BioMarin Pharmaceutical, Inc.BMRN

0.2%

Incyte Corp.INCY

0.2%

Universal Health Services, Inc.UHS

0.2%

Insmed, Inc.INSM

0.19%

Catalent, Inc.CTLT

0.18%

Bio-Techne Corp.TECH

0.18%

Royalty Pharma PlcRPRX

0.17%

Encompass Health Corp.EHC

0.17%

EXACT Sciences Corp.EXAS

0.17%

Solventum Corp.SOLV

0.17%

Charles River Laboratories International, Inc.CRL

0.16%

Henry Schein, Inc.HSIC

0.16%

Exelixis, Inc.EXEL

0.15%

Teleflex, Inc.TFX

0.15%

HealthEquity, Inc.HQY

0.15%

Penumbra, Inc.PEN

0.15%

Medpace Holdings, Inc.MEDP

0.14%

DaVita, Inc.DVA

0.14%

The Ensign Group, Inc.ENSG

0.14%

Chemed Corp.CHE

0.14%

Intra-Cellular Therapies, Inc.ITCI

0.14%

Vaxcyte, Inc.PCVX

0.14%

Masimo Corp.MASI

0.13%

Glaukos Corp.GKOS

0.12%

Sarepta Therapeutics, Inc.SRPT

0.12%

Jazz Pharmaceuticals PlcJAZZ

0.12%

Globus Medical, Inc.GMED

0.12%

Repligen Corp.RGEN

0.12%

Elanco Animal Health, Inc.ELAN

0.11%

Revolution Medicines, Inc.RVMD

0.11%

Bio-Rad Laboratories, Inc.BIO

0.11%

Merit Medical Systems, Inc.MMSI

0.1%

Lantheus Holdings, Inc.LNTH

0.1%

Halozyme Therapeutics, Inc.HALO

0.1%

Doximity, Inc.DOCS

0.1%

Blueprint Medicines Corp.BPMC

0.09%

Inspire Medical Systems, Inc.INSP

0.09%

Cytokinetics, Inc.CYTK

0.09%

Bruker Corp.BRKR

0.09%

Viking Therapeutics, Inc.VKTX

0.09%

Corcept Therapeutics, Inc.CORT

0.09%

RadNet, Inc.RDNT

0.09%

PROCEPT BioRobotics Corp.PRCT

0.08%

ADMA Biologics, Inc.ADMA

0.08%

Crinetics Pharmaceuticals, Inc.CRNX

0.08%

Integer Holdings Corp.ITGR

0.08%

Alkermes PlcALKS

0.08%

TG Therapeutics, Inc.TGTX

0.08%

Ionis Pharmaceuticals, Inc.IONS

0.08%

Haemonetics Corp.HAE

0.07%

Select Medical Holdings Corp.SEM

0.07%

Prestige Consumer Healthcare, Inc.PBH

0.07%

Madrigal Pharmaceuticals, Inc.MDGL

0.07%

ICU Medical, Inc.ICUI

0.07%

Dentsply Sirona, Inc.XRAY

0.07%

CRISPR Therapeutics AGCRSP

0.07%

Option Care Health, Inc.OPCH

0.06%

Organon & Co.OGN

0.06%

Guardant Health, Inc.GH

0.06%

Perrigo Co. PlcPRGO

0.06%

Ultragenyx Pharmaceutical, Inc.RARE

0.06%

Krystal Biotech, Inc.KRYS

0.06%

Envista Holdings Corp.NVST

0.06%

Acadia Healthcare Co., Inc.ACHC

0.06%

Avidity Biosciences, Inc.RNA

0.06%

CorVel Corp.CRVL

0.06%

Biohaven Ltd.BHVN

0.06%

Hims & Hers Health, Inc.HIMS

0.05%

Denali Therapeutics, Inc.DNLI

0.05%

Neogen Corp.NEOG

0.05%

Veracyte, Inc.VCYT

0.05%

Amedisys, Inc.AMED

0.05%

Axsome Therapeutics, Inc.AXSM

0.05%

LivaNova PlcLIVN

0.05%

Arcellx, Inc.ACLX

0.05%

Agios Pharmaceuticals, Inc.AGIO

0.05%

Rhythm Pharmaceuticals, Inc.RYTM

0.05%

PTC Therapeutics, Inc.PTCT

0.05%

Inari Medical, Inc.NARI

0.05%

Vericel Corp.VCEL

0.04%

TransMedics Group, Inc.TMDX

0.04%

BridgeBio Pharma, Inc.BBIO

0.04%

Enovis Corp.ENOV

0.04%

R1 RCM, Inc.RCM

0.04%

Twist Bioscience Corp.TWST

0.04%

Premier, Inc.PINC

0.04%

iRhythm Technologies, Inc.IRTC

0.04%

Catalyst Pharmaceuticals, Inc.CPRX

0.04%

Apellis Pharmaceuticals, Inc.APLS

0.04%

Azenta, Inc.AZTA

0.04%

CONMED Corp.CNMD

0.04%

Addus HomeCare Corp.ADUS

0.04%

QuidelOrtho Corp.QDEL

0.04%

Amicus Therapeutics, Inc.FOLD

0.04%

Springworks Therapeutics, Inc.SWTX

0.04%

LeMaitre Vascular, Inc.LMAT

0.04%

Arrowhead Pharmaceuticals, Inc.ARWR

0.03%

Ligand Pharmaceuticals, Inc.LGND

0.03%

NeoGenomics, Inc.NEO

0.03%

Supernus Pharmaceuticals, Inc.SUPN

0.03%

Omnicell, Inc.OMCL

0.03%

MannKind Corp.MNKD

0.03%

Astrana Health, Inc.ASTH

0.03%

Tandem Diabetes Care, Inc.TNDM

0.03%

IDEAYA Biosciences, Inc.IDYA

0.03%

Beam Therapeutics, Inc.BEAM

0.03%

ACADIA Pharmaceuticals, Inc.ACAD

0.03%

AtriCure, Inc.ATRC

0.03%

National HealthCare Corp.NHC

0.03%

Protagonist Therapeutics, Inc.PTGX

0.03%

Amphastar Pharmaceuticals, Inc.AMPH

0.03%

Geron Corp.GERN

0.03%

NovoCure Ltd.NVCR

0.03%

Fortrea Holdings, Inc.FTRE

0.03%

Scholar Rock Holding Corp.SRRK

0.03%

Iovance Biotherapeutics, Inc.IOVA

0.03%

Patterson Cos., Inc.PDCO

0.03%

Dyne Therapeutics, Inc.DYN

0.03%

Surgery Partners, Inc.SGRY

0.03%

Celldex Therapeutics, Inc.CLDX

0.03%

Integra LifeSciences Holdings Corp.IART

0.03%

Keros Therapeutics, Inc.KROS

0.03%

Akero Therapeutics, Inc.AKRO

0.03%

Teladoc Health, Inc.TDOC

0.03%

Dynavax Technologies Corp.DVAX

0.03%

RxSight, Inc.RXST

0.03%

Xencor, Inc.XNCR

0.02%

Kymera Therapeutics, Inc.KYMR

0.02%

U.S. Physical Therapy, Inc.USPH

0.02%

Myriad Genetics, Inc.MYGN

0.02%

BioCryst Pharmaceuticals, Inc.BCRX

0.02%

10X Genomics, Inc.TXG

0.02%

Immunovant, Inc.IMVT

0.02%

Cassava Sciences, Inc.SAVA

0.02%

Harmony Biosciences Holdings, Inc.HRMY

0.02%

Intellia Therapeutics, Inc.NTLA

0.02%

Tarsus Pharmaceuticals, Inc.TARS

0.02%

Pediatrix Medical Group, Inc.MD

0.02%

Harrow, Inc.HROW

0.02%

Nurix Therapeutics, Inc.NRIX

0.02%

Schrödinger, Inc.SDGR

0.02%

Edgewise Therapeutics, Inc.EWTX

0.02%

Syndax Pharmaceuticals, Inc.SNDX

0.02%

Travere Therapeutics, Inc.TVTX

0.02%

Progyny, Inc.PGNY

0.02%

Evolent Health, Inc.EVH

0.02%

Alignment Healthcare, Inc.ALHC

0.02%

Viridian Therapeutics, Inc.VRDN

0.02%

Recursion Pharmaceuticals, Inc.RXRX

0.02%

Certara, Inc.CERT

0.02%

Disc Medicine, Inc.IRON

0.02%

CareDx, Inc.CDNA

0.02%

Aurinia Pharmaceuticals, Inc.AUPH

0.02%

Innoviva, Inc.INVA

0.02%

Tilray Brands, Inc.TLRY

0.02%

Arcutis Biotherapeutics, Inc.ARQT

0.02%

The Pennant Group, Inc.PNTG

0.02%

Amneal Pharmaceuticals, Inc.AMRX

0.02%

Alphatec Holdings, Inc.ATEC

0.02%

Arvinas, Inc.ARVN

0.02%

STAAR Surgical Co.STAA

0.02%

Artivion, Inc.AORT

0.02%

Novavax, Inc.NVAX

0.02%

Phreesia, Inc.PHR

0.02%

Brookdale Senior Living, Inc.BKD

0.02%

Collegium Pharmaceutical, Inc.COLL

0.02%

AMN Healthcare Services, Inc.AMN

0.02%

ANI Pharmaceuticals, Inc.ANIP

0.02%

Praxis Precision Medicines, Inc.PRAX

0.02%

Owens & Minor, Inc.OMI

0.02%

Ocular Therapeutix, Inc.OCUL

0.01%

Kiniksa Pharmaceuticals International PlcKNSA

0.01%

AdaptHealth Corp.AHCO

0.01%

BioLife Solutions, Inc.BLFS

0.01%

Rocket Pharmaceuticals, Inc.RCKT

0.01%

Avanos Medical, Inc.AVNS

0.01%

Day One Biopharmaceuticals, Inc.DAWN

0.01%

Pacira Biosciences, Inc.PCRX

0.01%

Avid Bioservices, Inc.CDMO

0.01%

HealthStream, Inc.HSTM

0.01%

Castle Biosciences, Inc.CSTL

0.01%

Embecta Corp.EMBC

0.01%

Arcus Biosciences, Inc.RCUS

0.01%

ImmunityBio, Inc.IBRX

0.01%

Kura Oncology, Inc.KURA

0.01%

Establishment Labs Holdings, Inc.ESTA

0.01%

Anavex Life Sciences Corp.AVXL

0.01%

Spyre Therapeutics, Inc.SYRE

0.01%

Zymeworks, Inc.ZYME

0.01%

Vir Biotechnology, Inc.VIR

0.01%

Orthofix Medical, Inc.OFIX

0.01%

Varex Imaging Corp.VREX

0.01%

Pliant Therapeutics, Inc.PLRX

0.01%

Evolus, Inc.EOLS

0.01%

Cogent Biosciences, Inc.COGT

0.01%

Altimmune, Inc.ALT

0.01%

Surmodics, Inc.SRDX

0.01%

OPKO Health, Inc.OPK

0.01%

Ironwood Pharmaceuticals, Inc.IRWD

0.01%

Relay Therapeutics, Inc.RLAY

0.01%

Agilon Health, Inc.AGL

0.01%

EyePoint Pharmaceuticals, Inc.EYPT

0.01%

Enliven Therapeutics, Inc.ELVN

0.01%

Prothena Corp. PlcPRTA

0.01%

Phibro Animal Health Corp.PAHC

0.01%

Community Health Systems, Inc.CYH

0.01%

Liquidia Corp.LQDA

0.01%

SI-BONE, Inc.SIBN

0.01%

Adaptive Biotechnologies Corp.ADPT

0.01%

Emergent BioSolutions, Inc.EBS

0.01%

Simulations Plus, Inc.SLP

0.01%

Health Catalyst, Inc.HCAT

0.01%

Arcturus Therapeutics Holdings, Inc.ARCT

0.01%

GRAIL, Inc.GRAL

0.01%

OrthoPediatrics Corp.KIDS

0.01%

Pacific Biosciences of California, Inc.PACB

0.01%

Quanterix Corp.QTRX

0.01%

REGENXBIO, Inc.RGNX

0.01%

Revance Therapeutics, Inc.RVNC

0.01%

ZimVie, Inc.ZIMV

0.01%

Standard BioTools, Inc.LAB

0.01%

Theravance Biopharma, Inc.TBPH

0.01%

Cross Country Healthcare, Inc.CCRN

0.01%

DocGo, Inc.DCGO

0.01%

Phathom Pharmaceuticals, Inc.PHAT

0.01%

GoodRx Holdings, Inc.GDRX

0.01%

Treace Medical Concepts, Inc.TMCI

0.01%

CryoPort, Inc.CYRX

0.01%

Y-mAbs Therapeutics, Inc.YMAB

0.01%

Fulgent Genetics, Inc.FLGT

0.01%

Stoke Therapeutics, Inc.STOK

0.01%

Cerus Corp.CERS

0.01%

Enhabit, Inc.EHAB

0.01%

OraSure Technologies, Inc.OSUR

0.01%

Astria Therapeutics, Inc.ATXS

0%

Sana Biotechnology, Inc.SANA

0%

Allogene Therapeutics, Inc.ALLO

0%

Vanda Pharmaceuticals, Inc.VNDA

0%

Aclaris Therapeutics, Inc.ACRS

0%

uniQure NVQURE

0%

AngioDynamics, Inc.ANGO

0%

AnaptysBio, Inc.ANAB

0%

SIGA Technologies, Inc.SIGA

0%

Alector, Inc.ALEC

0%

Amylyx Pharmaceuticals, Inc.AMLX

0%

Accolade, Inc.ACCD

0%

Organogenesis Holdings, Inc.ORGO

0%

Korro Bio, Inc.KRRO

0%

4D Molecular Therapeutics, Inc.FDMT

0%

Inogen, Inc.INGN

0%

Aldeyra Therapeutics, Inc.ALDX

0%

SAGE Therapeutics, Inc.SAGE

0%

MeiraGTx Holdings PlcMGTX

0%

Dianthus Therapeutics, Inc.DNTH

0%

Editas Medicine, Inc.EDIT

0%

Fate Therapeutics, Inc.FATE

0%

Enanta Pharmaceuticals, Inc.ENTA

0%

ModivCare, Inc.MODV

0%

iTeos Therapeutics, Inc.ITOS

0%

Zentalis Pharmaceuticals, Inc.ZNTL

0%

MacroGenics, Inc.MGNX

0%

Nevro Corp.NVRO

0%

IGM Biosciences, Inc.IGMS

0%

Seer, Inc. (California)SEER

0%

Ventyx Biosciences, Inc.VTYX

0%

American Well Corp.AMWL

0%

Coherus BioSciences, Inc.CHRS

0%

Repare Therapeutics, Inc.RPTX

0%

Rapt Therapeutics, Inc.RAPT

0%

ALX Oncology Holdings, Inc.ALXO

0%

Design your own stock index

© Double Finance, 2024

Double is a registered investment adviser with the US Securities and Exchange Commission (SEC). While such registration does not imply a certain level of skill, it does require us to follow federal regulations that protect you, the investor. By law, we must provide investment advice that is in the best interest of our client. Please refer to Double's Form CRS for important additional information.

The publicly available portions of the Platform (i.e., the sections of the Platform that are available to individuals who are not party to a Client Agreement - including double.finance) are provided for educational purposes only and are not intended to provide legal, tax, or financial planning advice. To the extent that any of the content published on publicly available portions of the Platform may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Nothing on the publicly available portions of the Platform should be construed as a solicitation or offer, or recommendation, to buy or sell any security. All charts, figures, and graphs on the publicly available websites are for illustrative purposes only. Before investing, you should consider whether any investment, investment strategy, security, other asset, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. You are also encouraged to consult your legal, tax, or investment professional regarding your specific situation. Registration does not imply a certain level of skill or training.

Investing involves risk. The value of your investment will fluctuate, and you may gain or lose money.

The contents of the Platform may contain forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates, and projections about the financial industry, the economy, or Global Predictions itself. Forward-looking statements are not guarantees of the underlying expected actions or future performance and future results may differ significantly from those anticipated by the forward-looking statements. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statements.

¹ Data as of July 2024.

² Availability of tax loss harvesting depends on portfolio diversity.

³ As of November 8, 2024. The optional Cash Sweep program takes the cash sitting in your brokerage account and moves it to an FDIC-insured interest-earning deposit account. The current yield is 1.0%, rates subject to change at any time. The cash sweep program is made available in coordination with Apex Clearing Corporation. Please read the Important Disclosures for more information.

⁴ This analysis calculator tool is for illustrative purposes only and is not financial advice. We do not guarantee the accuracy of the results or their relevance to your particular circumstances. This calculator uses hypothetical historical data and does not take into account the effect of taxes on a taxable account. Hypothetical historical data is no guarantee of future performance and this calculator is not intended to predict actual performance. The input of different time periods, amounts, and fees will vary calculator results. Average ETF fee is based on the AUM weighted average of US ETFs as of September 2024, see more information. Note that you can purchase ETFs through Double, which may incur additional fees.

Full pricing details along with an FAQ can be found here

Data displayed in charts and graphics above are for illustrative purposes only and do not reflect actual investment results and are not a guarantee of future results.

By using double.finance, you accept our and . Double is only available to US residents.

See Double Finance Form ADV Part IIA for additional information. Double does not guarantee that the results of its advice, recommendations, or the objectives of its direct index or cash management strategies will be achieved. We make no assurance that the investment process will consistently lead to successful investing. Before you invest, you should carefully review and consider your investment objectives as well as the risks, charges, and expenses of the underlying securities. There is at least a $1,000 account minimum required to participate in Double's strategies, although some strategies may have higher minimums.

Double does not provide tax, or legal advice. Double's website, brokerage, and advisory services are not intended for persons of any jurisdiction where Double is not authorized to do business. Tax savings will vary from client to client due to many factors including market conditions, tax characteristics of securities, client-imposed investment restrictions, client tax rate or status, and changes in tax regulations.